CASI Pharmaceuticals, Inc. (CASI)
CASI Price and Sentiment
CASI Latest news
CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon.
CASI Pharmaceuticals, Inc. To Participate In Oppenheimer Fall Healthcare Life Sciences & MedTech Summit2021-09-20 07:00
ROCKVILLE, Md. and BEIJING, Sept.
Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Are these penny stocks worth the risk? The post Trending Penny Stocks To Buy For Under $3 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
The shares of CASI Pharmaceuticals, Inc. (Nasdaq: CASI) increased by over 16% pre-market. This is why it happened.
CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q2 2021 Results - Earnings Call Transcript
CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 44.44% and 16.46%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
CASI Pharmaceuticals To Report Second Quarter 2021 Financial Results And Host Conference Call August 12, 20212021-08-10 07:00
ROCKVILLE, Md. and BEIJING, Aug. 10, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the Company will host a conference call reviewing the second quarter highlights at 8:00 a.m.
Analysts Estimate CASI Pharmaceuticals, Inc. (CASI) to Report a Decline in Earnings: What to Look Out for2021-08-02 16:46
CASI Pharmaceuticals, Inc. (CASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.